Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Morinaga Nutritional Foods is a premier provider of functional ingredients and nutritional products, operating as a subsidiary of the Japanese dairy giant Morinaga Milk Industry. The company is globally recognized for its pioneering research in probiotics, specifically the Bifidobacterium longum BB536 strain, which is one of the most clinically studied probiotic strains in the world. Beyond probiotics, Morinaga produces high-value ingredients such as lactoferrin, postbiotics, and specialty proteins used in infant formula and clinical nutrition. Their business model encompasses both B2B ingredient supply and B2C consumer products, including the well-known Mori-Nu Silken Tofu brand. With a strong emphasis on scientific validation, the company continues to innovate in the fields of gut health, immunology, and healthy aging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Morinaga Nutritional Foods.